Cargando…
Cardiomyopathy associated with the Ala143Thr variant of the α-galactosidase A gene
OBJECTIVE: To investigate whether the Ala143Thr variant of the α-galactosidase A gene (A143T/GLA), with conflicting interpretations of pathogenicity, is associated with Fabry cardiomyopathy. METHODS: The index patient, a woman in her 60s with cardiomyopathy, was screened for variants in 59 cardiomyo...
Autores principales: | Valtola, Kati, Nino-Quintero, Juanita, Hedman, Marja, Lottonen-Raikaslehto, Line, Laitinen, Tomi, Maria, Maleeha, Kantola, Ilkka, Naukkarinen, Anita, Laakso, Markku, Kuusisto, Johanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146944/ https://www.ncbi.nlm.nih.gov/pubmed/31949022 http://dx.doi.org/10.1136/heartjnl-2019-315933 |
Ejemplares similares
-
Late-onset and classic phenotypes of Fabry disease in males with the GLA-Thr410Ala mutation
por: Valtola, Kati, et al.
Publicado: (2023) -
Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
por: Lauppe, Rosa Elisabeth, et al.
Publicado: (2021) -
Clinical disease presentation and ECG characteristics of LMNA mutation carriers
por: Ollila, Laura, et al.
Publicado: (2017) -
Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates
por: Janoušek, J, et al.
Publicado: (2009) -
Prospective development and validation of a model to predict heart failure hospitalisation
por: Cubbon, R M, et al.
Publicado: (2014)